CCCC
Price
$1.40
Change
-$0.12 (-7.89%)
Updated
Jun 27 closing price
Capitalization
100.82M
39 days until earnings call
EPRX
Price
$5.30
Change
+$0.68 (+14.72%)
Updated
Jun 27 closing price
Capitalization
192.14M
41 days until earnings call
Interact to see
Advertisement

CCCC vs EPRX

Header iconCCCC vs EPRX Comparison
Open Charts CCCC vs EPRXBanner chart's image
C4 Therapeutics
Price$1.40
Change-$0.12 (-7.89%)
Volume$8.25M
Capitalization100.82M
Eupraxia Pharmaceuticals
Price$5.30
Change+$0.68 (+14.72%)
Volume$28.44K
Capitalization192.14M
CCCC vs EPRX Comparison Chart in %
Loading...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CCCC vs. EPRX commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a Hold and EPRX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (CCCC: $1.42 vs. EPRX: $5.30)
Brand notoriety: CCCC and EPRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 584% vs. EPRX: 180%
Market capitalization -- CCCC: $100.82M vs. EPRX: $192.14M
CCCC [@Biotechnology] is valued at $100.82M. EPRX’s [@Biotechnology] market capitalization is $192.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 1 FA rating(s) are green whileEPRX’s FA Score has 0 green FA rating(s).

  • CCCC’s FA Score: 1 green, 4 red.
  • EPRX’s FA Score: 0 green, 5 red.
According to our system of comparison, CCCC is a better buy in the long-term than EPRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 3 TA indicator(s) are bullish while EPRX’s TA Score has 4 bullish TA indicator(s).

  • CCCC’s TA Score: 3 bullish, 6 bearish.
  • EPRX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, EPRX is a better buy in the short-term than CCCC.

Price Growth

CCCC (@Biotechnology) experienced а -0.01% price change this week, while EPRX (@Biotechnology) price change was +22.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

CCCC is expected to report earnings on Aug 06, 2025.

EPRX is expected to report earnings on Aug 08, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EPRX($192M) has a higher market cap than CCCC($101M). EPRX YTD gains are higher at: 67.192 vs. CCCC (-60.558). EPRX has higher annual earnings (EBITDA): -25.89M vs. CCCC (-102.74M). CCCC has more cash in the bank: 215M vs. EPRX (27.5M). EPRX has less debt than CCCC: EPRX (52.8K) vs CCCC (64.4M). CCCC has higher revenues than EPRX: CCCC (39.8M) vs EPRX (0).
CCCCEPRXCCCC / EPRX
Capitalization101M192M53%
EBITDA-102.74M-25.89M397%
Gain YTD-60.55867.192-90%
P/E RatioN/AN/A-
Revenue39.8M0-
Total Cash215M27.5M782%
Total Debt64.4M52.8K121,970%
TECHNICAL ANALYSIS
Technical Analysis
CCCCEPRX
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
67%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
57%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
74%
MACD
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
71%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
41%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
40%
Advances
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 1 day ago
84%
Declines
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 4 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
80%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
APHIX34.650.21
+0.61%
Artisan International Institutional
DURAX14.07N/A
N/A
DWS ESG International Core Eq A
MGTCX9.30N/A
N/A
Transamerica Mid Cap Growth C
GASFX28.42N/A
N/A
Hennessy Gas Utility Investor
MAMEX20.72N/A
N/A
MoA Mid Cap Equity Index Fund

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with KYMR. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
-6.59%
KYMR - CCCC
55%
Loosely correlated
-3.48%
CRBU - CCCC
55%
Loosely correlated
-5.19%
BEAM - CCCC
54%
Loosely correlated
-2.04%
FATE - CCCC
52%
Loosely correlated
-5.45%
RXRX - CCCC
51%
Loosely correlated
-6.94%
More

EPRX and

Correlation & Price change

A.I.dvisor tells us that EPRX and ETNB have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EPRX and ETNB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EPRX
1D Price
Change %
EPRX100%
+14.72%
ETNB - EPRX
28%
Poorly correlated
-1.01%
ACAD - EPRX
28%
Poorly correlated
-0.41%
CCCC - EPRX
28%
Poorly correlated
-6.59%
IOVA - EPRX
26%
Poorly correlated
-4.49%
ALEC - EPRX
25%
Poorly correlated
-1.33%
More